Skip to main content
. 2016 Sep 2;16(1):343. doi: 10.1186/s12906-016-1330-7

Table 2.

Participants baseline and medical characteristics of the groups

Characteristic Intervention (n = 12) Control (n = 11) P valuea
Age (years; Mean ± SD) 55.1 ± 2.5 60.5 ± 3.6 0.230
Range 36–65 34–80
Number nodes removed (Mean ± SD) 14.3 ± 2.6 11.2 ± 2.7 0.429
Range 5–30 2–25
How long lymphoedema (years; Mean ± SD) 4.9 ± 1.6 5.5 ± 1.9 0.900
Range 6 months–20 years 1 month–23 years
How long post-surgery (years; Mean ± SD) 1.2 ± 0.4 1.9 ± 0.7 0.822
Range 1 month–5 years 1 month–8 years
n % n % P valueb
Occupation
 Home, retired 5 (42) 8 (73) 0.280
 Employed 7 (58) 3 (27)
Fitness (self-scored)
 Low 2 (17) 1 (9)
 Medium 8 (67) 8 (73) 0.913
 High 2 (17) 2 (18)
Most significant exercise
 Walking 8 (67) 8 (73) 0.890
 Gardening 7 (58) 7 (64) 0.867
 Gym - organised exercise 1 (8) 8 (73) 0.006
Type of surgery
 Lumpectomy 5 (42) 3 (27)
 Mastectomy 7 (58) 8 (73) 0.882
Type of lymph dissection
 Sentinel node 0 1 (9)
 Axillary clearance 12 (75) 10 (73) 0.980
Stage of breast cancer
 Ductal Carcinoma In Situ (DCIS) 0 1 (9)
 1 3 (25) 4 (36)
 2 6 (50) 5 (45) 0.976
 3 3 (25) 1 (9)
Treatment
 Chemotherapy 8 (66) 6 (54) 0.867
 Radiotherapy 9 (75) 7 (64) 0.890
Most common area of radiotherapy
 Chest 7 (58) 7 (64)
 Axilla 2 (17) 2 (18) 0.909
 Axilla and chest 3 (25) 2 (18)
Lymphoedema dominant/non-dominant
 Dominant 7 (58) 7 (64) 0.867
 Non-dominant 5 (42) 4 (36)

*P < 0.05

a P values obtained using two-tailed independent samples t-test

b P values obtained using chi-square test with Yates correction